Clinical Research
Copyright ©2008 The WJG Press and Baishideng.
World J Gastroenterol. Jun 14, 2008; 14(22): 3497-3503
Published online Jun 14, 2008. doi: 10.3748/wjg.14.3497
Figure 1
Figure 1 Cumulative probability of colorectal cancer or dysplasia (A), cumulative incidence of immunosuppressors use (B), cumulative incidence of colonic or ileal surgical resection (C), from the IBD diagnosis date in cases (those with inflammatory bowel disease -associated with primary sclerosing cholangitis) vs controls (those with IBD without PSC).